Logo for Renovaro Inc

Renovaro Inc Investor Relations Material

Latest events

Logo for Renovaro Inc

Q4 2024

10 Oct, 2024
Logo for Renovaro Inc

Q4 2023

2 Oct, 2023
Access the full event backlog
Slides, Transcripts, and Reports from 12,000+ public companies

Latest reports from Renovaro Inc

Access all reports
Renovaro Inc. is a biotechnology company focused on developing advanced allogeneic cell and gene therapies. These therapies are designed to enhance immune system responses with the potential for long-term or life-long remission in some of the most challenging cancers, as well as the treatment or possible cure of serious infectious diseases, including HIV and Hepatitis B virus (HBV). The company leverages its proprietary platforms in gene and cell therapy to create therapeutic candidates aimed at hyper-stimulating the immune system to target and destroy cancer cells and virus-infected cells. Renovaro Inc. is headquartered in Los Angeles, California, and its shares are listed on the NASDAQ.